Back to Journals » OncoTargets and Therapy » Volume 15

Ovarian Cancer Therapy: Homologous Recombination Deficiency as a Predictive Biomarker of Response to PARP Inhibitors

Total article views   HTML views PDF downloads Totals
9,072 Dovepress* 6,025+ 160 6,185
PubMed Central* 3,047 326 3,373
Totals 9,072 486 9,558
*Since 4 October 2022
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed and Google Scholar